Loading clinical trials...
Loading clinical trials...
An Open Label, Randomized, Balanced, Three Treatment, Parallel Design, Pharmacokinetic Study of Intranasal TBS-1 Administration to Hypogonadal Men
Conditions
Interventions
10.0 mg of Testosterone, 4.0% TID
13.5 mg of Testosterone, 4.5% B.I.D
+1 more
Locations
3
United States
Quality of Life Medical and Research Center
Tucson, Arizona, United States
Pharmax Research Clinic Inc.
Miami, Florida, United States
Regional Urology LLC
Shreveport, Louisiana, United States
Start Date
August 1, 2010
Primary Completion Date
November 1, 2010
Completion Date
December 1, 2010
Last Updated
May 23, 2018
NCT06019182
NCT06689085
NCT06841328
NCT03851627
NCT06094036
NCT06691815
Lead Sponsor
Acerus Pharmaceuticals Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions